GlassScriptPhysician profile
Damian Rasch
NPI 1295977122
$26,876.57
in general payments reported to CMS, 2019-2025
53 companies · $3,644 in 2025
The $3,644 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,121 · 2020: $641 · 2021: $1,532 · 2022: $3,558 · 2023: $5,982 · 2024: $6,398 · 2025: $3,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $3,973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,050.14 |
| Travel and Lodging | $3,973.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,081.90 | 2021-2025 | Linq II, Aurora Ev-Icd Mri Surescan |
| Cvrx, INC. | $2,973.57 | 2022-2025 | Barostim Neo System |
| Abbott Laboratories | $2,711.11 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $1,935.54 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Pfizer INC. | $1,442.92 | 2019-2025 | |
| Medtronic Vascular, INC. | $1,431.04 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,282.50 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,123.12 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Amgen INC. | $891.18 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $842.01 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $714.84 | 2019-2025 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $685.55 | 2021-2024 | Nexletol, Nexlizet |
| Sanofi-Aventis U.S. LLC | $655.31 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $515.60 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $502.89 | 2019-2024 | Xarelto |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $440.95 | 2019-2025 | Evkeeza |
| Actelion Pharmaceuticals US, INC. | $392.59 | 2019-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $387.11 | 2019-2024 | Lifevest |
| Abiomed | $357.58 | 2023-2025 | Impella |
| Alnylam Pharmaceuticals INC. | $351.95 | 2022-2025 | Amvuttra |
| Kestra Medical Technology Services, INC. | $345.01 | 2023-2025 | Assure Wcd |
| Irhythm Technologies, INC. | $282.56 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Bardy Diagnostics, INC. | $281.23 | 2019-2022 | |
| Novo Nordisk INC | $248.89 | 2021-2024 | Ozempic, Rybelsus |
| Heartflow, INC. | $204.41 | 2019-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $194.50 | 2021-2023 | Arcalyst |
| Lundbeck LLC | $163.55 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $135.73 | 2019 | |
| Biosense Webster, INC. | $135.05 | 2022 | |
| Impulse Dynamics (USA) INC. | $134.84 | 2022-2023 | Optimizer |
| Amarin Pharma, INC. | $115.09 | 2020-2022 | |
| Lexicon Pharmaceuticals, INC. | $113.67 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $111.75 | 2022-2025 | Kengreal |
| Gilead Sciences, INC. | $78.93 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $75.32 | 2024 | Arcalyst |
| Philips North America LLC | $63.88 | 2019-2024 | (Ck4) Mcot |
| Daiichi Sankyo INC. | $57.85 | 2022-2023 | Injectafer |
| Microtransponder, INC. | $46.38 | 2025 | |
| Baxter Healthcare | $45.22 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Lilly USA, LLC | $38.65 | 2022-2025 | Mounjaro, Zepbound |
| Celgene Corporation | $37.54 | 2023 | Camzyos |
| Glaxosmithkline, LLC. | $35.42 | 2025 | Arexvy, Shingrix |
| Cleerly, INC. | $27.13 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Biotronik INC. | $24.45 | 2022 | |
| Bridgebio Pharma, INC. | $21.63 | 2025 | Attruby |
| Atricure, INC. | $20.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.63 | 2022 | |
| Scpharmaceuticals INC. | $20.51 | 2023 | |
| Inspire Medical Systems, INC. | $18.23 | 2025 | Inspire |
| Angiodynamics, INC. | $17.72 | 2021 | |
| Trevena, INC. | $15.67 | 2022 | |
| Itamar Medical INC | $14.06 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damian Rasch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.